We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12185-010-0648-z | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!